CXorf49B
gene geneOn this page
Summary
CXorf49B (chromosome X open reading frame 49B, HGNC:34229) is a protein-coding gene on chromosome Xq13.1, encoding Uncharacterized protein CXorf49 (A8MYA2).
At a glance
- MANE Select transcript:
NM_001145139
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34229 |
| Approved symbol | CXorf49B |
| Name | chromosome X open reading frame 49B |
| Location | Xq13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000215113 |
| Ensembl biotype | protein_coding |
| Entrez | 100132994 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 retained_intron, 1 protein_coding
ENST00000440412, ENST00000542739
RefSeq mRNA: 1 — MANE Select: NM_001145139
NM_001145139
CCDS: CCDS75992
Canonical transcript exons
ENST00000542739 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001677324 | 71767031 | 71767204 |
| ENSE00002259905 | 71763349 | 71764647 |
| ENSE00002311905 | 71765224 | 71765380 |
| ENSE00003524803 | 71765924 | 71766000 |
| ENSE00003593858 | 71766883 | 71766924 |
| ENSE00003668531 | 71766283 | 71766328 |
Expression profiles
Bgee: expression breadth broad, 47 present calls, max score 90.96.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0293 / max 6.2249, expressed in 15 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 209729 | 0.0293 | 15 |
Top tissues by expression
111 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.96 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.68 | gold quality |
| right testis | UBERON:0004534 | 65.22 | gold quality |
| testis | UBERON:0000473 | 64.22 | gold quality |
| left testis | UBERON:0004533 | 63.62 | gold quality |
| fallopian tube | UBERON:0003889 | 40.35 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 39.34 | silver quality |
| tibial nerve | UBERON:0001323 | 37.56 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| left uterine tube | UBERON:0001303 | 36.93 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| sural nerve | UBERON:0015488 | 35.89 | gold quality |
| omental fat pad | UBERON:0010414 | 35.85 | gold quality |
| right lung | UBERON:0002167 | 35.66 | silver quality |
| body of stomach | UBERON:0001161 | 35.62 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| placenta | UBERON:0001987 | 35.35 | gold quality |
| stomach | UBERON:0000945 | 34.72 | gold quality |
| right atrium auricular region | UBERON:0006631 | 34.62 | gold quality |
| apex of heart | UBERON:0002098 | 34.45 | gold quality |
| muscle tissue | UBERON:0002385 | 34.39 | gold quality |
| bone marrow | UBERON:0002371 | 34.34 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 33.56 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| lymph node | UBERON:0000029 | 32.94 | gold quality |
| gall bladder | UBERON:0002110 | 32.61 | gold quality |
| fundus of stomach | UBERON:0001160 | 32.36 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.47 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
6 targeting CXorf49B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8065 | 99.19 | 70.38 | 1289 |
| HSA-MIR-1843 | 98.97 | 66.07 | 838 |
| HSA-MIR-4802-5P | 98.97 | 66.26 | 833 |
| HSA-MIR-302F | 98.44 | 69.02 | 1776 |
| HSA-MIR-203B-3P | 97.82 | 66.27 | 979 |
| HSA-MIR-6805-5P | 95.79 | 64.86 | 670 |
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gm4779 | ENSMUSG00000045010 |
| mus_musculus | 8030474K03Rik | ENSMUSG00000046774 |
| mus_musculus | 4933412E24Rik | ENSMUSG00000071749 |
| mus_musculus | Gm3858 | ENSMUSG00000118638 |
| rattus_norvegicus | 4933412E24Rikl | ENSRNOG00000004914 |
| rattus_norvegicus | Cxhxorf49B | ENSRNOG00000025200 |
| rattus_norvegicus | Cxhxorf49 | ENSRNOG00000025211 |
| rattus_norvegicus | Cxhxorf49l1 | ENSRNOG00000060462 |
Paralogs (2): CXorf49 (ENSG00000215115), (ENSG00000283599)
Protein
Protein identifiers
Uncharacterized protein CXorf49 — A8MYA2 (reviewed: A8MYA2)
All UniProt accessions (1): A8MYA2
RefSeq proteins (1): NP_001138611* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027822 | CXorf49 | Family |
Pfam: PF15483
UniProt features (6 total): region of interest 3, compositionally biased region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MYA2-F1 | 49.96 | 0.05 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 7 (showing top):
chrXq13, GSE14026_TH1_VS_TH17_UP, GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP, GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP, GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN, GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP, GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
206 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CXorf49B | CXorf51A | A0A1B0GTR3 | 691 |
| CXorf49B | PWWP4 | A0A494C071 | 691 |
| CXorf49B | TCP11X2 | Q5H9J9 | 598 |
| CXorf49B | SPRR2G | Q9BYE4 | 435 |
| CXorf49B | PSAPL1 | Q6NUJ1 | 375 |
| CXorf49B | SPRR1B | P22528 | 348 |
| CXorf49B | VCX3B | Q9H321 | 315 |
| CXorf49B | UGT8 | Q16880 | 307 |
| CXorf49B | PNMA6A | P0CW24 | 305 |
| CXorf49B | RLBP1 | P12271 | 268 |
| CXorf49B | RBMY1D | P0C7P1 | 268 |
| CXorf49B | TSPY1 | P09002 | 259 |
| CXorf49B | RHOXF1 | Q8NHV9 | 249 |
| CXorf49B | SPATA22 | Q8NHS9 | 203 |
| CXorf49B | MEIOB | Q8N635 | 201 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A096LP49, A0A8V8TNH8, A0A8V8TPE2, A2VE02, A5D7I0, A6NDY2, A6NGG8, A6NIJ5, A6NNJ1, A8MXJ8, A8MYA2, B1ASB6, B2RW88, D6RGX4, O60269, P0C7V4, P0C7W8, P0C7W9, P0C7X0, P0DV75, P0DV76, Q2KIS6, Q2NL68, Q3SY00, Q4R736, Q4V8B5, Q5RCQ2, Q5SZB4, Q5VZ46, Q5XIK6, Q658T7, Q66JV7, Q6NS69, Q6PAC4, Q6ZMY3, Q76N32, Q7TSA6, Q7Z591, Q80VW7, Q80X53
Diamond homologs: A5PKC7, A8MYA2, Q3KR64, Q9D454
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
621 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:71765223:GCTTC:G | acceptor_gain | 1.0000 |
| X:71765376:CTCCG:C | donor_gain | 1.0000 |
| X:71765377:TCCG:T | donor_gain | 1.0000 |
| X:71765378:CCG:C | donor_gain | 1.0000 |
| X:71765379:CGG:C | donor_loss | 1.0000 |
| X:71765380:GGT:G | donor_loss | 1.0000 |
| X:71765381:G:GG | donor_gain | 1.0000 |
| X:71766265:C:CA | acceptor_gain | 1.0000 |
| X:71766925:G:GG | donor_gain | 1.0000 |
| X:71764628:A:G | donor_gain | 0.9900 |
| X:71764634:TCCC:T | donor_gain | 0.9900 |
| X:71764648:G:GG | donor_gain | 0.9900 |
| X:71764652:G:GG | donor_gain | 0.9900 |
| X:71765218:TTTTA:T | acceptor_loss | 0.9900 |
| X:71765222:A:AG | acceptor_gain | 0.9900 |
| X:71765223:G:GG | acceptor_gain | 0.9900 |
| X:71765223:GC:G | acceptor_gain | 0.9900 |
| X:71765223:GCT:G | acceptor_gain | 0.9900 |
| X:71765223:GCTT:G | acceptor_gain | 0.9900 |
| X:71765379:CG:C | donor_gain | 0.9900 |
| X:71765380:GG:G | donor_gain | 0.9900 |
| X:71765385:GTCTT:G | donor_gain | 0.9900 |
| X:71765918:TTTCA:T | acceptor_loss | 0.9900 |
| X:71765919:TTCA:T | acceptor_loss | 0.9900 |
| X:71765922:A:C | acceptor_loss | 0.9900 |
| X:71765980:G:GT | donor_gain | 0.9900 |
| X:71765990:G:T | donor_gain | 0.9900 |
| X:71766881:A:AG | acceptor_gain | 0.9900 |
| X:71766882:G:GG | acceptor_gain | 0.9900 |
| X:71766922:GAA:G | donor_gain | 0.9900 |
AlphaMissense
3333 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:71763586:T:C | F55L | 0.867 |
| X:71763588:C:A | F55L | 0.867 |
| X:71763588:C:G | F55L | 0.867 |
| X:71766314:T:C | L497P | 0.847 |
| X:71765992:T:C | C484R | 0.840 |
| X:71763604:T:C | F61L | 0.837 |
| X:71763606:C:A | F61L | 0.837 |
| X:71763606:C:G | F61L | 0.837 |
| X:71766293:T:C | L490P | 0.832 |
| X:71764195:T:C | F258L | 0.813 |
| X:71764197:C:A | F258L | 0.813 |
| X:71764197:C:G | F258L | 0.813 |
| X:71766285:C:G | C487W | 0.813 |
| X:71766283:T:A | C487S | 0.808 |
| X:71766284:G:C | C487S | 0.808 |
| X:71766283:T:C | C487R | 0.794 |
| X:71764432:T:C | F337L | 0.790 |
| X:71764434:T:A | F337L | 0.790 |
| X:71764434:T:G | F337L | 0.790 |
| X:71765992:T:A | C484S | 0.783 |
| X:71765993:G:C | C484S | 0.783 |
| X:71765994:T:G | C484W | 0.768 |
| X:71764156:T:C | F245L | 0.747 |
| X:71764158:C:A | F245L | 0.747 |
| X:71764158:C:G | F245L | 0.747 |
| X:71766323:A:C | Q500P | 0.737 |
| X:71766326:T:C | L501P | 0.736 |
| X:71766885:G:C | A503P | 0.721 |
| X:71766284:G:A | C487Y | 0.720 |
| X:71766894:T:C | F506L | 0.718 |
dbSNP variants (sampled 36 via entrez): RS1181967377 (X:71762055 C>T), RS1202727726 (X:71762461 G>A), RS1231786125 (X:71761884 C>T), RS1356746186 (X:71762483 C>T), RS1439444939 (X:71762278 C>G), RS1556222755 (X:71767383 T>C), RS1556229065 (X:71763431 C>T), RS1556229071 (X:71763453 T>G), RS1556229075 (X:71763561 C>T), RS1556229080 (X:71763742 G>A), RS1556229085 (X:71763802 G>T), RS1556229091 (X:71763851 A>G), RS1556229097 (X:71763899 G>C), RS1556229103 (X:71764181 C>T), RS1556229109 (X:71764268 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.